IP Verse

Insys competitive analysis

Loading summary...

Latest patents of Insys opposed by its competitors

Explore Insys's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3302437
Dec 21, 2022Stable Cannabinoid Formulations1

Latest publications and patents of Insys New

Explore the latest publications and patents granted to Insys, showcasing their recent innovations and technological advancements.

Last updated on: Oct 18, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Insys

EP3302437
Dec 21, 2022Stable Cannabinoid FormulationsGranted And Under Opposition

Latest PTAB cases involving Insys

Discover the latest PTAB cases involving Insys, highlighting their recent legal challenges and patent disputes.

Last updated on: Oct 24, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Insys

IPR2017-00503Dec 16, 2016INSYSGW PHARMAFinal Written Decision
IPR2015-01797Aug 24, 2015COALITION FOR AFFORDABLE DRUGS XIINSYS PHARMAInstitution Denied
IPR2015-01799Aug 24, 2015COALITION FOR AFFORDABLE DRUGS XIINSYS PHARMAInstitution Denied
IPR2015-01800Aug 24, 2015COALITION FOR AFFORDABLE DRUGS XIINSYS PHARMAInstitution Denied

Peer Comparison New

IP litigation analysis comparing Insys with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
INSYS - 11 -
CARDIOL THERAPEUTICS1 - - -
GW PHARMA - 1 - 1